Clinical Trial Update: Treatment Research Investigating Depression Effects on Neuroimmune Targets (TRIDENT) [NA]

View source ↗

Summary

The TRIDENT clinical trial is investigating how depression affects neuroimmune targets in individuals with HIV infection and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Major Depressive Disorder

Snippet

Sponsor: Florida International University | Conditions: Depression, HIV-1-infection | NA | Status: RECRUITING